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Abstract 
Introduction and Aims. Practice nurses (PN) are an alternative workforce for cessation support in primary 
care, but their role and effectiveness is underdeveloped and underresearched. This study evaluated a 
model of smoking cessation intervention in Australian general practice based on PNs. Smokers were 
identified by their general practitioner (GP) and referred to the PN for cessation support over four 
counselling visits and offered free nicotine patches. Design and Methods. Pre- and post-study using 
mixed quantitative and qualitative methods. Cessation outcomes were collected by patient self-report at 
6months. Semistructured interviews were conducted with PNs and GPs to provide qualitative data on the 
acceptability of the model. Results. The project involved 31 PNs, 35 GPs and 498 patients from 19 general 
practices in Sydney. Mean age of participating patients was 46years and 61% were female. Mean number 
of PN counselling visits was 3.1. At 6month follow up the point prevalence abstinence rate was 22% and 
continuous abstinence rate was 16%. Participants who had attended for four or more counselling visits 
with the PN were significantly more likely to quit. PNs and GPs expressed enthusiasm for the PN role in 
smoking cessation and belief in its value and feasibility. Discussion and Conclusions. Substantial rates of 
cessation were found in this uncontrolled study and the role was well accepted by PNs and GPs. The 
model shows promise as a means of providing cessation support in Australian primary care and further 
research in a randomised trial is warranted. 2010 Australasian Professional Society on Alcohol and other 
Drugs. 
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Abstract
Introduction and Aims. Practice nurses (PN) are an alternative workforce for cessation support in primary care, but their
role and effectiveness is underdeveloped and underresearched.This study evaluated a model of smoking cessation intervention
in Australian general practice based on PNs. Smokers were identified by their general practitioner (GP) and referred to the PN
for cessation support over four counselling visits and offered free nicotine patches. Design and Methods. Pre- and post-study
using mixed quantitative and qualitative methods. Cessation outcomes were collected by patient self-report at 6 months.
Semistructured interviews were conducted with PNs and GPs to provide qualitative data on the acceptability of the model.
Results. The project involved 31 PNs, 35 GPs and 498 patients from 19 general practices in Sydney. Mean age of
participating patients was 46 years and 61% were female. Mean number of PN counselling visits was 3.1. At 6 month follow
up the point prevalence abstinence rate was 22% and continuous abstinence rate was 16%. Participants who had attended for
four or more counselling visits with the PN were significantly more likely to quit. PNs and GPs expressed enthusiasm for the
PN role in smoking cessation and belief in its value and feasibility. Discussion and Conclusions. Substantial rates of
cessation were found in this uncontrolled study and the role was well accepted by PNs and GPs.The model shows promise as
a means of providing cessation support in Australian primary care and further research in a randomised trial is warranted.
[Zwar NA, Richmond RL, Forlonge G, Hasan I. Feasibility and effectiveness of nurse-delivered smoking cessation
counselling combined with nicotine replacement in Australian general practice. Drug Alcohol Rev 2011;30:583–588]
Key words: general practice, practice nurse, nicotine replacement therapy.
Introduction
General practice has great potential for supporting
smoking cessation. In countries with a developed
primary care system, such as Australia, more than 80%
of the population visits a general practitioner (GP) at
least once a year [1]. There is clear evidence that
smoking cessation advice from a physician has an effect
and that this effect can be increased substantially if brief
advice is combined with other evidence-based support,
such as pharmacotherapy [2].Translating this potential
into sustained activity, however, has proved difficult.
GPs have been encouraged to offer smoking cessation
advice and support and some have attended training
[3]. Despite this, the number of patients who report
receiving advice on smoking cessation from GPs is low
[4]. In an Australian study of GPs’ use of evidence-
based approaches only 32% provided written materials
and 28% set a quit date [5]. Barriers raised by GPs to
engaging in greater efforts in smoking cessation
include: perception of lack of effect; lack of GP time;
lack of GP skills; reluctance to raise the issue due to
perceived patient sensitivity about smoking; and per-
ceived lack of patient motivation [6].
Alternative models to providing accessible smoking
cessation support have been specialised referral ser-
vices, such as the English Smoking Cessation Services.
Evaluation of these services has shown validated
52 week abstinence rate of 15% [7]. Over time the
English services moved more towards one-to-one
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counselling (rather than group) and towards primary
care rather than specialised settings. These changes
occurred partially in response to consumer demand
and the difficulty of organising groups [7,8].
An alternative model for enhanced smoking cessa-
tion support is provision of advice in the practice by
general practice nurses (PN). Face-to-face support for
smoking cessation provided within the practice may
appeal to smokers given the accessibility and familiar-
ity of the general practice setting. This may include
smokers who are unlikely to use a telephone service,
such as people from culturally and linguistically diverse
backgrounds.
A number of studies have explored the effectiveness
of PN interventions to support smoking cessation either
as a standalone or multiple risk factor intervention,
although none in the Australian context [9–17]. In a
study by Vetter and Ford there was a significant benefit
at 6 month follow up [11], another study demonstrated
a reduction in smoking in those who were retained in
the intervention [14] and a third study showed a sig-
nificant reduction in cigarettes smoked per day [15]. All
other studies showed no significant differences. Limita-
tions of these studies included the low uptake of the
nursing intervention [9] and intervention designs that
provided only a one-off nurse consultation and a lack of
follow up [10]. Additionally, there were low retention
rates among smokers in these studies.The difficulties in
retention of this group as study participants may have
been responsible for the small effect sizes and lack of
significance seen in some studies [18].
We conducted a study to develop the role and test the
effectiveness of PN-delivered behavioural support plus
free nicotine patches in the Australian primary care
context. Australia has strong tobacco control policies
[19] and low overall smoking prevalence with a rate of
daily smoking of 16.6% (18.0% in men and 15.2% in
women) [20].Telephone Quitline services are provided
nationally, but the only widely available face-to-face
support for cessation is from generalist primary care
services, such as GPs and community pharmacists.This
study used mixed methods to examine not only the
impact of PN support on cessation rates but also the
feasibility and acceptability of the service model to
patients, PNs and GPs.
Design and methods
Study design
A pre–post study with 6 month follow up was con-
ducted in two Divisions of General Practice (local GP
organisations) in SouthWest Sydney and a nearby rural
area. All practices from these Divisions were invited to
participate via a letter and notice in the Division
newsletter. Practices were eligible if they had one or
more PNs.
Intervention
Practice nurses were provided with a 4 h training
program based on Australian clinical practice guide-
lines [2], which covered smoking cessation counselling,
role of pharmacotherapy with a focus on use of nicotine
replacement therapy (NRT) and project procedures.
The nurses were provided with smoking cessation
resources, including the guidelines and a counselling
checklist designed for each patient visit. The initial
training was followed by access to mentoring and
support from the project officer (G. F.). The project
officer also telephoned the nurses on a weekly basis and
conducted regular practice visits to maintain contact
and support. During a practice visit PNs were trained
in the use of a Bedfont ED50 Smokelyser. The PNs
took a leading role in providing counselling but were
supported by the GPs and were also able to offer par-
ticipants free nicotine patches. GPs identified smokers
interested in quitting and referred these patients to the
PN for a series of weekly counselling visits of approxi-
mately 30 min duration over a 4 week period. The
activities at these visits are shown in Table 1. This
schedule of weekly visits over 4 weeks was based on the
English smoking treatment service model [7]. The
nurses offered Quitline referral as a source of further
support during the quit attempt. Patients attending the
nurse could access an 8 week course of nicotine patches
at no cost. Other pharmacotherapies were not subsi-
dised by the project, but eligible patients could receive
bupropion subsidised by the Pharmaceutical Benefits
Scheme with a prescription from the GP.
Outcome measures
Quantitative measures of outcomes were measures of
service utilisation and measures of smoking status.The
Table 1. Intervention elements







✓ ✓ ✓ ✓
Nicotine patches provided ✓ ✓ ✓
Quitline referral offered ✓
Cessation counselling
support
✓ ✓ ✓ ✓
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latter were self-reported point prevalence abstinence
(no smoking in seven days preceding assessment) and
continuous abstinence (no smoking from quit date to
assessment) at 4 weeks and 6 months after the initial
nurse visit. PNs were asked to measure exhaled carbon
monoxide using a Bedfont EC50 Smokelyser at the
4 week and 6 month follow-up visits.
Participating patients were asked in the 6 month
follow-up questionnaire for feedback on the smoking
cessation support received from the PN. GPs and PNs
were asked to take part in a semistructured interview
face-to-face or by telephone to provide qualitative data
on the service model.
Data analysis
spss version 16.0.1 (SPSS Inc, Chicago, IL, USA) was
used for analysis of quantitative data. Descriptive ana-
lytical methods were used to analyse patients’ demo-
graphic characteristics, service utilisation, use of
pharmacotherapies and measures of smoking status.To
assess whether the number of nurse visits (less than
four vs. four or more) was associated with smoking
cessation cross-tabulation (2 ¥ 2) was done and
Pearson c2-test was applied.The same method was used
to assess whether patient nicotine dependence as mea-
sured by the Fagerström score (0–5 = low to medium
dependence vs. >5 = high to very high dependence) was
associated with success in cessation.
Thematic analysis was used to summarise the quali-
tative findings of the semistructured interviews [21].




Of a total of 89 practices in Macarthur Division and 19
in Southern Highlands there were 17 in Macarthur and
seven in Southern Highlands who employed at least
one PN and were therefore eligible to participate. Of
these 12 (63%) from Macarthur and seven (100%)
from Southern Highlands participated. The project
involved 31 PNs and 35 GPs from the participating
practices. Following PN training there was substantial
use of the mentoring from the project officer with a
total of 397 support contacts with the 31 PNs (mean
13, range 2–20).
A total of 498 patients attended the PN for an
assessment visit and consented to take part in the
project. Of these 344 (69.1%) completed the 4 week
and 378 (75.9%) the 6 month follow-up assessments.
The mean age of the 498 patients recruited at baseline
was 46.4 (range 18–62) and 61.2% were female. The
mean number of cigarettes smoked per day by the
participants was 24.1 (SD: 10.5) and the mean dura-
tion of smoking was 29.8 years (SD: 13.1). According
to the Fagerström score 43.6% of the participants had
nicotine dependency level of very low to medium
(score: 0–5) and for 54.4% the dependency level was
high to very high (score: 6+). Less than half (44.2%) of
the participants mentioned that they lived with a
smoker.
The mean number of PN counselling visits over the
first 4 weeks was 3.1 (range 1–7) while the mean
number of GP visits was 0.3 (range 0–5). GP visits
could have been for any reason and not necessarily
related to smoking cessation. Most participants in the
intervention either did not use the NSW Quitline at all
(54%) or only once (17%), but it was used two or more
times by a significant minority (30%). Overall 494
(99%) participants chose to use pharmacotherapy.The
most popular choice was NRT (474, 95%) followed by
bupropion (14, 3%). Choice of drug was not recorded
for 6 (1%) of participants. The most common form of
NRT was patch (368; 74% of participants). One
hundred and six participants (21%) chose to use com-
bination NRT. At the 6 month follow-up point 374
participants reported actually using NRT (mean dura-
tion of use 6.2 weeks) and 14 participants reported
using bupropion (mean duration of use 6.6 weeks).
Point prevalence and continuous abstinence rates at
4 week and 6 month follow-up points are shown in
Table 2. Participants lost to follow up were assumed to
be continuing smokers. Because of difficulties with
availability of Smokelysers, expired carbon monoxide
validation of smoking status was not carried out in a
substantial number of patients. The details of partici-
pants tested are shown in Table 2. Participants who
attended for four or more consultations with PNs had
significantly higher cessation rates at 6 months than
participants who attended less than four times: point
prevalence abstinence 32% versus 9% (P < 0.0001),
continuous abstinence 25% versus 3% (P < 0.0001).
Participants with very low to medium nicotine depen-
dence (0–5 on Fagerström Score) had significantly
higher point prevalence cessation rates than those
with high to very high dependence (score >5); point
prevalence abstinence 36% versus 21% (P < 0.001).
However, continuous abstinence was not significantly
different between these groups: 23% versus 17%
(P < 0.163).
The use of NRT for the recommended duration
(8 weeks) did not show any significant impact on point
prevalence and continuous abstinence rates. Among
participants who used NRT for 8 weeks or more the
point prevalence abstinence rate was 30.5% compared
with 25.0% who used NRT for less than 8 weeks
(P > 0.05). Among participants who used NRT for
Nurse-delivered smoking cessation support 585
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8 weeks or more the continuous abstinence rate was
21.8% compared with 17.2% who used NRT for less
than 8 weeks (P > 0.05).
Participating patients were asked in the 6 month
follow-up questionnaire for feedback on the smoking
cessation support received from the PN. Of 391 par-
ticipants who responded 385 (98%) rated the support
provided as helpful (19%) or very helpful (79%). Par-
ticipants were asked what could have made the quit
attempt easier or more successful. Of the 362 responses
to this question less than 2% commented that the
program could have been improved and all of these
comments indicated that they may have been more
successful if they had been able to have more sessions
with the PN.
Qualitative findings
Qualitative evaluation of the intervention model
through semistructured interviews was conducted
with PNs and GPs. Semistructured interviews with 21
PNs and 11 GPs were completed before saturation
of themes was achieved and no new themes were
emerging. The qualitative data were grouped into
themes to report the findings. These were: perceived
value of the role; barriers to PNs taking on this role;
resources provided to support the role; and sustain-
ability issues.
All the PNs interviewed were enthusiastic about the
role, thought it enhanced their skills and that it
expanded their scope of practice. They also thought it
was an appropriate role for PNs, which could benefit
patients.
. . . enhances the role as Practice Nurse. Adds to
depth of skills. Satisfying to help people quit smoking
PN
(PN) really in charge . . . often not (previously) given
enough scope as PNs—PN
One-third of the PNs volunteered the opinion that PNs
have more time than GPs available for this kind of
counselling. Some PNs believed that patients feel par-
ticularly comfortable with the nurse.
Patients are . . . more relaxed and open with the
Practice Nurse—PN
Patients were very open to having the nurse not the
doctor—PN
Finding time in their day that could be dedicated to the
role of smoking cessation counsellor, and quarantined
from other tasks, was the major barrier identified. The
majority of PNs thought a longer training program was
needed.The telephone mentoring and support from the
project officer was highly valued.
Had never done it before—a lot to absorb in half a
day—PN
Good to have support because it was a new area of
work—PN
The PNs gave positive feedback on the resources pro-
vided, in particular, the clinical practice guidelines,
but were less positive about the support provided to
patients by the Quitline. More than half of the PNs
reported that patients had experienced difficulties
using the Quitline service. Some PNs reported that
patients preferred the face-to-face contact with the
PN to a telephone call from an ‘anonymous’ person.
On the other hand some PNs reported receiving posi-
tive comments from patients about the Quitline
stating that patients valued the service and found it
reliable. The provision of free NRT patches was seen
as a major factor in motivating patients to make a quit
attempt and in improving adherence and cessation
outcomes.
Huge incentive . . . really attracted people—PN
Table 2. Smoking status and CO validation results at 4 week and 6 month follow up
Smoking status
4 weeks (n = 344) 6 months (n = 378)
As stated by participant
As validated by
Smokelysera As stated by participant
As validated by
Smokelysera
Not smoked in last
7 days (point
prevalence)
195 (39.2% of 498
participants at
baseline)
Not smoked = 154 108 (21.7% of 498
participants at
baseline)
Not smoked = 69
Smoked = 7 Smoked = 5
Not tested = 34 Not tested = 34
Not smoked since quit
day (continuous
abstinence)
129 (25.9% of 498
participants at
baseline)
Not smoked = 103 79 (15.9% of 498
participants at
baseline)
Not smoked = 52
Smoked = 3 Smoked = 0
Not tested = 23 Not tested = 27
aExpired CO of >10 ppm was taken as indicating possible continuation of smoking.
586 N. A. Zwar et al.
© 2010 Australasian Professional Society on Alcohol and other Drugs
If paying they would not have stayed on patches for
the whole 8 weeks—PN
Key issues in sustainability were remuneration for
PN consultations and access to training and support.
Very similar themes emerged from the GP inter-
views. GPs expressed positive views about the value
of offering a quit smoking service in the practice.
They saw it as a suitable role for PNs and welcomed
the PN involvement. Again the major barrier was PN
time.
An excellent program that has potentially save many
lives—GP
It reinforced they could get help in the surgery even
if they didn’t quit.—GP
It fits with the nursing role.The autonomy suited the
nurses.—GP
Very time-consuming for PNs although the practice
was willing to accommodate this because it was good
for patients . . . —GP
All the GPs interviewed thought an on-going funding
mechanism was essential if the role was to be sustained.
If we had a Medicare item number we could refer all
our patients wanting to quit to them.—GP
Discussion
The study showed positive outcomes in terms of ces-
sation rates. The 6 month point prevalence cessation
rate at 6 months of 21% is not directly comparable to
the outcome of the English Smoking Cessation Ser-
vices as the evaluation of those services reports
12 month outcomes. However, if adjusted for a relapse
rate of 0.27 between 6 months and 12 months [22],
the estimated 12 month self-reported point prevalence
cessation rate in this study is 15%.This is the same rate
as the validated 52 week abstinence rate of 15%
reported by the English Smoking Cessation Services.
Smoking rates are lower in Australia so the context is
different, but this study suggests that a primary care-
based PN-led model may be as effective in the Austra-
lian context as the English services have been in the
context of the British health system and population.
The quit rates reported also compare favourably with
the outcomes of physician advice and nurse advice
reported in Cochrane reviews with the important
proviso that those are meta-analyses of controlled trials
[23,24]. Our positive findings in this uncontrolled
study contrast with the lack of effect found in some
randomised trials. As previously mentioned there were
problems in the controlled trials with low uptake of the
intervention and/or low rates of follow up [9,18], but
clearly our intervention model needs to be tested in a
randomised trial.
The patient follow-up questionnaire and the quali-
tative evaluation with PNs and GPs found that the
service model was well supported by all parties. Both
PNs and GPs thought the role was a suitable one to be
taken on by PNs. The amount of training provided to
PNs was limited to 4 h, and should be expanded in
future studies. Perhaps as a consequence of the short
duration of the training the telephone mentoring sub-
sequently provided was extensively used by the PNs.
This role may be less needed if training was expanded
and could possibly be provided by a Quitline counsel-
lor, providing further integration between general
practice smoking cessation support and the Quitline
service.
Although the role was welcomed and is congruent
with the expanding role of PNs in Australian general
practice [25], it was clear that without an ongoing
source of funding for PN consultation time the role
could not be sustained.There are a number of possible
funding mechanisms in the Australian context, includ-
ing expanding the existing PN consultation items that
can be claimed from Medicare by GPs for services
provided by PNs on their behalf or through block
funding for PNs.
The study has a number of limitations, the major
one being the lack of a control group. The study does
not therefore provide high-level evidence of the effi-
cacy of cessation support from PNs, but the effect
observed justifies further investigation in the form of a
randomised trial. A further limitation is that it was not
possible in the study to differentiate the effect of PN
counselling from the effect of smoking cessation phar-
macotherapy. The most widely used form of pharma-
cotherapy in the study was nicotine transdermal
patches. In previous research nicotine patches have
shown effect sizes of around 17% in controlled studies
with 6 months to a year of follow up [26], but there
have been concerns that success rates may not be as
high in over the counter settings where support and
follow up is not provided [27]. In such complex inter-
ventions with a number of interacting components
[28] it can be difficult, if not impossible, to differen-
tiate the effects of each component in quantitative
terms. As we did in this study qualitative methods
can be used to help understand the processes of the
intervention. It would be important to include quali-
tative process evaluation in a controlled study of a PN
intervention.
Conclusions
Practice nurse-supported cessation in combination
with NRT produced cessation rates similar to special-
Nurse-delivered smoking cessation support 587
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ised services and taking on this role was welcomed by
both PNs and GPs. The model shows promise as a
means of providing cessation support in Australian
primary care and further research in a randomised trial
is warranted.
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